Sporadic Lymphangioleiomyomatosis Disease: A Case Report
نویسندگان
1 Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
2 Department of Internal Medicine, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran
3 Department of Internal Medicine, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran
4 Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
5 Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
6 Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
7 Department of Internal Medicine, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran
doi
10.30476/ijms.2022.95521.2689چکیده
Pulmonary Lymphangioleiomyomatosis (LAM) is a rare disease of the lung and lymphatic system that primarily affects women of childbearing age. LAM is a progressive disease with a terrible prognosis, which worsens over time and is extremely difficult to treat. In this study, we discuss the case of a 31-year-old woman with LAM who was initially misdiagnosed with leiomyoma and the way that led to a true diagnosis and effective treatment. Following a precise diagnosis based on comprehensive clinical data and particular immunohistochemical tests, sirolimus treatment was initiated, and the patient entirely responded to the treatment. This case report demonstrated that LAM is an uncommon condition that is challenging to diagnose, which causes its treatment to be delayed.
